TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7212987

Group type: EXPERIMENTAL
Intervention: EEG foci on the left side
Number of subjects: 2543

Group type: COMPARATOR
Intervention: EEG foci on the right side
Number of subjects: 2543

Group type: EXPERIMENTAL
Intervention: Temporal region foci
Number of subjects: 2543

Group type: EXPERIMENTAL
Intervention: Occipital region foci
Number of subjects: 2543

Group type: EXPERIMENTAL
Intervention: Delta foci
Number of subjects: 2543

Group type: EXPERIMENTAL
Intervention: All diagnoses
Number of subjects: 2543

Group type: EXPERIMENTAL
Intervention: EEG examiners
Number of subjects: 2543

Group type: EXPERIMENTAL
Intervention: Alpha waves, focal dysrhythmias, theta wave foci
Number of subjects: 2543

Group type: EXPERIMENTAL
Intervention: General left preponderance of EEG foci
Number of subjects: 2543
Study: 30535871

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pioglitazone
Number of subjects: 100
Study: 29030697

Group type: EXPERIMENTAL
Intervention: Geomagnetic storm (S) exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quiet (Q) exposure
Number of subjects: 0
Study: 29933530

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine comprehensive therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Modern Western Medicine treatment
Number of subjects: 51
Study: 22612425

Group type: EXPERIMENTAL
Intervention: Cooling protocol (20‐min water immersion, 15 °C)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Noncooling protocol
Number of subjects: 9
Study: 22341998

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT)
Number of subjects: 145
Study: 20381870

Group type: EXPERIMENTAL
Intervention: Homozygous risk genotype for rs10490924 in LOC387715/ARMS2
Number of subjects: 114

Group type: COMPARATOR
Intervention: Homozygous nonrisk genotype for rs10490924 in LOC387715/ARMS2
Number of subjects: 114

Group type: COMPARATOR
Intervention: Other genetic variants (CFH, C2, C3, APOE, TLR3)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Progression to central GA from extrafoveal GA and development of bilateral GA
Number of subjects: 114
Study: 18532895

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham acupuncture (Control)
Number of subjects: 12
Study: 15798915

Group type: EXPERIMENTAL
Intervention: Povidone-iodine diluted 1:100 mouthwashes
Number of subjects: 132

Group type: COMPARATOR
Intervention: Normal saline mouthwashes
Number of subjects: 132
Study: 12461401

Group type: EXPERIMENTAL
Intervention: Proactive intervention
Number of subjects: 6179

Group type: EXPERIMENTAL
Intervention: Passive intervention
Number of subjects: 6179

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6179
Study: 10757273

Group type: EXPERIMENTAL
Intervention: Vitamin C (200 mg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IU)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Vitamin E (200 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 9023788

Group type: EXPERIMENTAL
Intervention: Moclobemide (300 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fluoxetine (200 mg/day)
Number of subjects: 42
Study: 1890934

Group type: EXPERIMENTAL
Intervention: Purified sulfur (0.5-1 g mixed with 0.25 g of glucose, administered every 2-3 hours before irradiation)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (a mixture of egg powder with glucose)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No protective means used (21 patients)
Number of subjects: 34
Study: 6410897

Group type: EXPERIMENTAL
Intervention: Acidophilus milk (240 ml, three times a day for 2 weeks)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Unaltered milk (for 1 week)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Acidophilus milk (for 1 additional week)
Number of subjects: 79
Study: 29960810

Group type: EXPERIMENTAL
Intervention: Probiotic (PR) group received a probiotic formulation containing Bifidobacterium breve BR03 and B. breve B632 for 3 months.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PL) group, received no active treatment.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy Children (HC) group, sampled only once (T0).
Number of subjects: 40
Study: 29342495

Group type: EXPERIMENTAL
Intervention: SPIKES training with video reviews
Number of subjects: 61

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 61
Study: 27323614

Group type: EXPERIMENTAL
Intervention: Sinusitis Mixture (SM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Compound Sodium Chloride Injection (Control)
Number of subjects: 50
Study: 25137874

Group type: EXPERIMENTAL
Intervention: Valsartan 80 to 320 mg/day (n = 18)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-renin-angiotensin-aldosterone-system blocking antihypertensive agents (control, n = 15)
Number of subjects: 33
Study: 22447644

Group type: EXPERIMENTAL
Intervention: Hearing conservation intervention (not specified in detail)
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Use of hearing protection and safety measures
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Higher levels of recreational and occupational noise sources, and chemical exposures with ototoxic potential
Number of subjects: 392
Study: 20146169

Group type: EXPERIMENTAL
Intervention: Atorvastatin, 20 mg daily
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Simvastatin, 20 mg daily
Number of subjects: 64
Study: 17909315

Group type: EXPERIMENTAL
Intervention: ALVAC boosted by bivalent gp120
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: ALVAC boosted by ogp160
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Subunit-boosted vaccine
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: ogp160-boosted vaccine
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: gp120 B/E-boosted vaccine
Number of subjects: 130
Study: 16184581

Group type: EXPERIMENTAL
Intervention: Caffeine 400 mg administered 30 min prior to sleep
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo administered prior to sleep
Number of subjects: 15
Study: 12100442

Group type: COMPARATOR
Intervention: CQ alone
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: SP alone
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: SP plus CQ
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: SP plus PCM
Number of subjects: 153
Study: 10421112

Group type: EXPERIMENTAL
Intervention: I ministernotomy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Full sternotomy
Number of subjects: 34
Study: 8033770

Group type: EXPERIMENTAL
Intervention: Assessment of cardiovascular risk factors in patients with mild to moderate hypertension
Number of subjects: 60
Study: 3594304

Group type: EXPERIMENTAL
Intervention: 50 burns
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 100 burns
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 10 burns
Number of subjects: 38
Study: 30680649

Group type: EXPERIMENTAL
Intervention: Self-management education by the teach-back method
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study: 28865152

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) 300/120 mg once daily for 8 weeks (arm A)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Sofosbuvir (400 mg once daily) + RBV (600-1000 mg weight-based, twice daily) for 12 weeks (arm B)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) for 12 weeks in CERTAIN-1 study
Number of subjects: 136
Study: 26859236

Group type: EXPERIMENTAL
Intervention: ECT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ECT + AET
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: AET
Number of subjects: 60
Study: 24793735

Group type: EXPERIMENTAL
Intervention: Facial symmetry
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Feminine versions of faces
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Facial non-averageness (distinctiveness)
Number of subjects: 64
Study: 22677762

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of insulin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Frequent (every 3h) subcutaneous injections of insulin
Number of subjects: 47
Study: 20653168

Group type: EXPERIMENTAL
Intervention: Acupuncture plus blood-letting by a three-edged needle
Number of subjects: 100

Group type: COMPARATOR
Intervention: Simple acupuncture
Number of subjects: 100
Study: 18612727

Group type: EXPERIMENTAL
Intervention: Interactive spaced-education (ISE) program, 18-week duration, 6 e-mails per week for 6 weeks, repeated for 2 additional cycles.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Interactive spaced-education (ISE) program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (Cohort B)
Number of subjects: 120
Study: 15901972

Group type: COMPARATOR
Intervention: Prednisolone alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Prednisolone plus fusidic acid
Number of subjects: 18
Study: 11817991

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment with concomitant benazepril therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antihypertensive treatment without benazepril
Number of subjects: 0
Study: 10756613

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention in eight practices for one year (September 1996 to August 1997) at a cost of 163,000 Pounds.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (eight matched practices without pharmacist intervention).
Number of subjects: 16
Study: 8785399

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA; 4 to 5 mg/kg per day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Enalapril (10 to 30 mg daily)
Number of subjects: 41
Study: 1809708

Group type: EXPERIMENTAL
Intervention: Low viscosity bone cement
Number of subjects: 41

Group type: COMPARATOR
Intervention: High viscosity bone cement
Number of subjects: 41
Study: 6219689

Group type: EXPERIMENTAL
Intervention: I% metronidazole cream
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo (cream base)
Number of subjects: 81
Study: 30786974

Group type: EXPERIMENTAL
Intervention: Open surgical bypass (OSB)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Plain balloon angioplasty (PBA)
Number of subjects: 311
Study: 29121350

Group type: EXPERIMENTAL
Intervention: Individualized FSH dosing (450/225 IU for RCT1, 100 IU for RCT2)
Number of subjects: 1515

Group type: COMPARATOR
Intervention: Standard FSH dosing (150 IU)
Number of subjects: 1515

Group type: EXPERIMENTAL
Intervention: Individualized FSH dosing
Number of subjects: 1515
Study: 25639994

Group type: EXPERIMENTAL
Intervention: STEP (Specialized Treatment Early in Psychosis)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 120
Study: 24565591

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (Group I, n = 23)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard percutaneous coronary intervention without preconditioning (Group II, n = 25)
Number of subjects: 48
Study: 22580981

Group type: EXPERIMENTAL
Intervention: Kettlebell swing training (KB)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Jump squat power training (JS)
Number of subjects: 21
Study: 19570621

Group type: EXPERIMENTAL
Intervention: Delayed reward discounting (DRD) for money
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Baseline discounting
Number of subjects: 57
Study: 17690015

Group type: EXPERIMENTAL
Intervention: TrP anesthetic infiltration (group 1) on the 3rd, 10th, 30th, and 60th day after threshold measurement.
Number of subjects: 78

Group type: COMPARATOR
Intervention: No treatment (group 2).
Number of subjects: 78

Group type: COMPARATOR
Intervention: Normal subjects (control group).
Number of subjects: 78
Study: 15247107

Group type: EXPERIMENTAL
Intervention: Open lung concept (OLC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 24
Study: 21901907

Group type: EXPERIMENTAL
Intervention: 200,000 IU of vitamin A
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: 50,000 IU of vitamin A
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Both supplemented groups (200,000 IU and 50,000 IU)
Number of subjects: 404
Study: 9829646

Group type: COMPARATOR
Intervention: 500 lx light
Number of subjects: 34

Group type: COMPARATOR
Intervention: Dark
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Propranolol 10 mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Dim light (20-30 lx)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Varying light intensities (300 to 2000 lx)
Number of subjects: 34
Study: 7860686

Group type: EXPERIMENTAL
Intervention: Laparoscopic totally pre-peritoneal hernia repair
Number of subjects: 241

Group type: COMPARATOR
Intervention: Shouldice technique
Number of subjects: 241
Study: 2347652

Group type: EXPERIMENTAL
Intervention: Org 10172 administered as a single intravenous bolus of 2400 anti‐Xa units at start of dialysis
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Org 10172 administered as a single bolus of 3200 anti‐Xa units at start of dialysis
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard heparin (3250‐4750 I.U. heparin at start of hemodialysis followed by continuous infusion of 2000‐2700 I.U. per hour)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups (including Org 10172 and heparin)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Org 10172
Number of subjects: 36
Study: 486891

Group type: EXPERIMENTAL
Intervention: Bolus injection of 60 ml of sodium iothalamate 70%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Infusion of a larger dose of contrast agent
Number of subjects: 0
Study: 31964564

Group type: EXPERIMENTAL
Intervention: Co-located contraceptive services at well-baby visits
Number of subjects: 446

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Co-located contraceptive services at well-baby visits (for those who accepted the visit)
Number of subjects: 446
Study: 29886416

Group type: EXPERIMENTAL
Intervention: Stronger habit (associated with higher nebuliser adherence)
Number of subjects: 61
Study: 28011757

Group type: EXPERIMENTAL
Intervention: Riociguat (up to 2.5 mg three times daily)
Number of subjects: 261
Study: 25453380

Group type: EXPERIMENTAL
Intervention: Frozen Hoodia (3 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo cubes
Number of subjects: 0
Study: 24879965

Group type: EXPERIMENTAL
Intervention: Training group (TG) - weight-lifting exercises for 6 muscle groups (2 sets of 8 repetitions at 80% of 1-repetition maximum)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Training group (TG)
Number of subjects: 46
Study: 21568628

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 274

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 274
Study: 19770322

Group type: EXPERIMENTAL
Intervention: Radioguided localization
Number of subjects: 134

Group type: COMPARATOR
Intervention: Wire localization
Number of subjects: 134
Study: 17561009

Group type: EXPERIMENTAL
Intervention: Norethisterone 50 microg/day + 17beta-estradiol 350 microg/day
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Norethisterone 175 microg/day + 17beta-estradiol 350 microg/day
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Norethisterone 550 microg/day + 17beta-estradiol 350 microg/day
Number of subjects: 333

Group type: COMPARATOR
Intervention: Oral norethisterone acetate 1 mg/day + 17beta-estradiol 2 mg/day
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 333
Study: 15709712

Group type: EXPERIMENTAL
Intervention: Allogeneic irradiated RCC-cell-line cells (ACHN-IL-2) admixed with autologous metastatic formalin-treated tumour cells, administered subcutaneously, 4-20 injections (mean 10 +/- 4), average of 92 x 10(6) ACHN-IL-2 transfected cells.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group receiving standard immunotherapy without the vaccine.
Number of subjects: 30
Study: 11795345

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0
Study: 9732298

Group type: EXPERIMENTAL
Intervention: Dietary γ-linolenic acid (GLA)
Number of subjects: 0
Study: 8273793

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg/day continuously for 5 years (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Seasonal prophylactic treatment with ranitidine 300 mg/day for 8 weeks in spring and fall (Group B)
Number of subjects: 80
Study: 3054641

Group type: EXPERIMENTAL
Intervention: Pirenzepine (11 patients)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) - one swallow tablet 4 times a day (11 patients)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) - two swallow tablets twice daily (16 patients)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) - two buffered swallow tablets twice daily (14 patients)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) - two chew tablets twice daily (22 patients)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Patients cleared of C pylori
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Patients rebiopsied 44‐137 days following treatment
Number of subjects: 74
Study: 31640804

Group type: EXPERIMENTAL
Intervention: Mobile phone addiction (average score 73.77±11.48 for boys, 74.64±12.28 for girls)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Sense of loneliness (average score 43.22±5.16 for boys, 42.82±5.30 for girls)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Correlation between mobile phone addiction and sense of loneliness
Number of subjects: 439
Study: 28319586

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 37
Study: 25742531

Group type: EXPERIMENTAL
Intervention: Workplace psychosocial intervention
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1630
Study: 23922092

Group type: EXPERIMENTAL
Intervention: Repositioning of routine management
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Foam dressing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Gender, hypertension history, and BMI
Number of subjects: 90
Study: 21892573

Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet (LGI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-glycemic index diet (HGI)
Number of subjects: 12
Study: 19954715

Group type: EXPERIMENTAL
Intervention: Equasym Retard 20 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Medikinet retard 20 mg
Number of subjects: 14
Study: 17406138

Group type: EXPERIMENTAL
Intervention: Enuretic alarm therapy (group 1)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Desmopressin therapy (group 2)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Enuretic alarm therapy as secondary treatment (group 3)
Number of subjects: 103
Study: 14993506

Group type: EXPERIMENTAL
Intervention: High dialysis dose (HDD) group (target Kt/V(eq) of 1.4)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High protein (HP) diet (1.3 g/kg of ideal body weight/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Regular protein (RP) diet (0.9 g/kg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High dialysis dose (HDD) group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Regular dialysis dose (RDD) group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High protein (HP) diet
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Increasing dialysis dose
Number of subjects: 50
Study: 11563997

Group type: EXPERIMENTAL
Intervention: Ranitidine 75 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Famotidine 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9258137

Group type: EXPERIMENTAL
Intervention: 200 mcg oral desmopressin
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: 400 mcg oral desmopressin
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: 600 mcg oral desmopressin
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 8416326

Group type: EXPERIMENTAL
Intervention: Visual estimates before PTCA
Number of subjects: 305

Group type: COMPARATOR
Intervention: Quantitative angiography before PTCA
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Visual estimates immediately after PTCA
Number of subjects: 305

Group type: COMPARATOR
Intervention: Quantitative angiography immediately after PTCA
Number of subjects: 305

Group type: COMPARATOR
Intervention: Quantitative measurements at follow-up
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Visual estimates at follow-up
Number of subjects: 305
Study: 2944924

Group type: EXPERIMENTAL
Intervention: nortriptyline or phenelzine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 29117738

Group type: EXPERIMENTAL
Intervention: High-frequency transcutaneous electrical nerve stimulation (TENS) plus semi-supervised exercise for 35 minutes a day for 20 sessions (4 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Semi-supervised exercise alone
Number of subjects: 70
Study: 28744892

Group type: EXPERIMENTAL
Intervention: Decision-theoretic design for phase II trials
Number of subjects: 0
Study: 25977408

Group type: EXPERIMENTAL
Intervention: 4-mg nicotine lozenges
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Quitting support materials and coaching phone calls
Number of subjects: 152
Study: 24674975

Group type: EXPERIMENTAL
Intervention: CWI (10.3°C ± 0.2°C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thermoneutral water immersion placebo (TWP) (34.7°C ± 0.1°C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thermoneutral water immersion control (TWI) (34.7°C ± 0.1°C)
Number of subjects: 30
Study: 22543342

Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100